A comparative biodistribution study of polymeric and lipid-based nanoparticles

Area of Science:

• Nanomedicine
• Pharmacokinetics
• Drug Delivery

Background:

• Biodistribution of nanoencapsulated drugs depends on nanoparticle properties, not always the drug itself.
• Understanding formulation impact is crucial for effective nanomedicine development.

Purpose of the Study:

• To compare the biodistribution of two distinct nanoformulations: nanostructured lipid carriers (NLCs) with IR780-oleyl and polymeric nanoparticles (PNPs) with cabazitaxel.
• To investigate the influence of dose and time on the biodistribution profiles of these nanoformulations in rats.

Main Methods:

• Comparative biodistribution study in healthy rats.
• Quantification of encapsulated cargo (IR780-oleyl and cabazitaxel) in blood and organs up to 14 days post-injection.
• Analysis of dose linearity and organ-specific accumulation.

Main Results:

• Significant differences in biodistribution were observed between NLCs and PNPs.
• Cabazitaxel (PNPs) exhibited a >50-fold higher organ-to-blood concentration ratio compared to IR780-oleyl (NLCs).
• Cabazitaxel showed increased brain accumulation with dose and notable, prolonged lung accumulation.

Conclusions:

• Nanoformulation type critically influences drug biodistribution and organ targeting.
• Cabazitaxel-loaded PNPs demonstrate promising accumulation in lung and brain tissues.
• Further research into cabazitaxel PNPs could explore therapeutic applications in lung and brain cancers, potentially overcoming current dose-limiting toxicities.